• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CGS 6.02% $1.10

COGSTATE LTD - News & Media

Cogstate Limited is a neuroscience technology company optimizing brain health assessments... Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.More

No News & Media currently available.

(20min delay)
Last
$1.10
Change
0.063(6.02%)
Mkt cap ! $187.8M
Open High Low Value Volume
$1.06 $1.11 $1.06 $1.871M 1.741M

Buyers (Bids)

No. Vol. Price($)
1 20000 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.19 5853 1
View Market Depth
Last trade - 15.59pm 23/08/2024 (20 minute delay) ?
Last
$1.10
  Change
0.063 ( 5.29 %)
Open High Low Volume
$1.06 $1.11 $1.06 4361
Last updated 15.59pm 23/08/2024 ?
CGS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.